IMR Press / CEOG / Volume 43 / Issue 4 / DOI: 10.12891/ceog2152.2016

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 46 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Open Access Original Research
Role of mean platelet volume and neutrophil/lymphocyte ratio to predict single-dose methotrexate treatment success in tubal ectopic pregnancy
Show Less
1 Department of Obstetrics and Gynecology, Umraniye Medical and Research Hospital, Istanbul, (Turkey)
Clin. Exp. Obstet. Gynecol. 2016, 43(4), 509–511; https://doi.org/10.12891/ceog2152.2016
Published: 10 August 2016
Abstract

Objective: The aim of the study was to evaluate the value of mean platelet volume (MPV) and neutrophil/lymphocyte ratio (NLR) to predict single-dose methotrexate (MTX) treatment success in ectopic pregnancy (EP). Materials and Methods: A total of 115 EP diagnosed and hemodynamically stable women were enrolled in the study and divided into two groups as group 1, the treatment success group (n = 78) and group 2, the treatment failure group (n = 37). The authors compared the groups in terms of MPV and NLR. Results: MPV and NLR levels were higher in MTX treatment successful group than in failure group.The cut-off values of MPV and NLR were determined as 10.1 fL and 1.82, respectively. These cut off values showed similar sensitivity and specificity in prediction of MTX treatment success. Conclusion: MPV and NLR can be used as reliable markers to predict single-dose MTX treatment success however further studies are needed.
Keywords
Mean platelet volume
Neutrophil/lymphocyte ratio
Ectopic pregnancy
Share
Back to top